| Literature DB >> 26221526 |
Hiroya Iwase1, Muhei Tanaka1, Yukiko Kobayashi2, Sayori Wada2, Masashi Kuwahata2, Yasuhiro Kido2, Masahide Hamaguchi1, Mai Asano1, Masahiro Yamazaki1, Goji Hasegawa3, Naoto Nakamura1, Michiaki Fukui1.
Abstract
AIMS/Entities:
Keywords: Low-carbohydrate diet; Metabolic syndrome; Type 2 diabetes mellitus
Year: 2015 PMID: 26221526 PMCID: PMC4511307 DOI: 10.1111/jdi.12326
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Clinical characteristics of patients
| 149 | |
| Age (years) | 65.7 ± 9.3 |
| Sex (male/female) | 77/72 |
| Body mass index (kg/m2) | 24.0 ± 4.2 |
| Systolic blood pressure (mmHg) | 129.6 ± 14.6 |
| Diastolic blood pressure (mmHg) | 72.4 ± 10.4 |
| HbA1c (%) | 6.9 ± 0.9 |
| Total cholesterol (mmol/L) | 4.8 ± 0.8 |
| High-density lipoprotein cholesterol (mmol/L) | 1.6 ± 0.4 |
| Low-density lipoprotein cholesterol (mmol/L) | 2.6 ± 0.8 |
| Triglycerides (mmol/L) | 1.5 ± 1.0 |
| Uric acid (μmol/L) | 298.4 ± 78.9 |
| Estimated glomerular filtration rate (mL/min/1.73 m2) | 77.9 ± 21.7 |
| Urinary albumin excretion (mg/g creatinine) | 46.9 ± 94.1 |
| No. metabolic risk factors | 2.5 ± 2.0 |
| Metabolic syndrome (–/+) | 82/67 |
| Insulin treatment (–/+) | 116/33 |
| Antihypertensive drugs (–/+) | 79/70 |
| Statins (–/+) | 91/58 |
| Total energy intake (kcal) | 1821.5 ± 400.1 |
| Carbohydrate intake (g) | 248.8 ± 60.9 |
| Protein intake (g) | 67.2 ± 18.5 |
| Animal protein intake (g) | 36.1 ± 14.4 |
| Vegetable protein intake (g) | 31.1 ± 8.4 |
| Fat intake (g) | 53.3 ± 20.2 |
| Animal fat intake (g) | 23.3 ± 10.5 |
| Vegetable fat intake (g) | 29.9 ± 12.9 |
| Sodium intake (g) | 10.5 ± 3.5 |
| Carbohydrate energy/total energy (%) | 56.9 ± 7.7 |
| Protein energy/total energy (%) | 15.3 ± 2.4 |
| Fat energy/total energy (%) | 26.9 ± 6.4 |
| Potential renal acid load score (mEq/day) | 5.7 ± 11.8 |
| Net endogenous acid production score (mEq/day) | −8.7 ± 0.3 |
Data are number of patients or mean ± standard deviation.
HbA1c, hemoglobin A1c.
Figure 1Relationships of carbohydrate energy/total energy with (a) animal or (b) vegetable protein energy/total energy, or (c) potential renal acid load (PRAL) or (d) net endogenous acid production (NEAP) score.
Clinical characteristics of patients divided into four subgroups according to the median of animal or vegetable protein energy/total energy or potential renal acid load or net endogenous acid production score
| Animal protein energy/total energy | Vegetable protein energy/total energy | |||||
|---|---|---|---|---|---|---|
| ≤7.7% | ≥7.8% |
| ≤6.5% | ≥6.6% |
| |
| 74 | 75 | – | 74 | 75 | – | |
| Age (years) | 63.9 ± 8.8 | 67.5 ± 9.5 | 0.0183 | 66.4 ± 10.2 | 65.0 ± 8.4 | 0.3687 |
| Sex (male/female) | 40/34 | 37/38 | 0.5642 | 48/26 | 29/46 | 0.0014 |
| Body mass index (kg/m2) | 24.1 ± 3.9 | 23.9 ± 4.5 | 0.7010 | 24.5 ± 4.0 | 23.5 ± 4.3 | 0.1203 |
| Systolic blood pressure (mmHg) | 131.5 ± 14.4 | 127.7 ± 14.5 | 0.1107 | 130.8 ± 14.6 | 128.4 ± 14.5 | 0.3191 |
| HbA1c (%) | 7.0 ± 1.1 | 6.7 ± 0.7 | 0.0935 | 7.0 ± 1.1 | 6.8 ± 0.7 | 0.2008 |
| Low-density lipoprotein cholesterol (mmol/L) | 2.6 ± 0.7 | 2.6 ± 0.8 | 0.6041 | 2.7 ± 0.7 | 2.5 ± 0.8 | 0.3556 |
| Triglycerides (mmol/L) | 1.5 ± 0.9 | 1.5 ± 1.0 | 0.7747 | 1.7 ± 1.0 | 1.4 ± 0.9 | 0.0511 |
| Estimated glomerular filtration rate (mL/min/1.73 m2) | 79.8 ± 22.6 | 75.9 ± 20.8 | 0.2718 | 75.7 ± 22.4 | 80.0 ± 20.9 | 0.2288 |
| Metabolic syndrome (–/+) | 40/34 | 42/33 | 0.8113 | 30/44 | 52/23 | 0.0004 |
| Total energy intake (kcal) | 1810.5 ± 438.6 | 1832.4 ± 360.7 | 0.7397 | 1902.2 ± 360.9 | 1741.9 ± 422.7 | 0.0139 |
| Carbohydrate energy/total energy (%) | 61.3 ± 6.2 | 52.7 ± 6.7 | <0.0001 | 55.5 ± 7.5 | 58.4 ± 7.8 | 0.0247 |
| Protein energy/total energy (%) | 13.6 ± 1.6 | 16.9 ± 1.9 | <0.0001 | 15.0 ± 2.3 | 15.6 ± 2.5 | 0.1039 |
| Animal protein energy/total energy (%) | 5.8 ± 1.2 | 9.9 ± 1.8 | <0.0001 | 8.2 ± 2.5 | 7.5 ± 2.4 | 0.0809 |
| Vegetable protein energy/total energy (%) | 7.0 ± 1.3 | 6.7 ± 1.2 | 0.1729 | 5.8 ± 0.6 | 7.9 ± 0.9 | <0.0001 |
| Fat energy/total energy (%) | 24.3 ± 5.5 | 29.5 ± 6.2 | <0.0001 | 28.2 ± 6.2 | 25.6 ± 6.4 | 0.0122 |
| Animal fat energy/total energy (%) | 8.7 ± 2.7 | 14.1 ± 3.7 | <0.0001 | 12.5 ± 4.4 | 10.3 ± 3.6 | 0.0013 |
| Vegetable fat energy/total energy (%) | 14.1 ± 4.0 | 14.9 ± 4.9 | 0.2864 | 14.1 ± 4.2 | 15.0 ± 4.7 | 0.2615 |
| Sodium intake (g) | 9.6 ± 3.2 | 11.5 ± 3.5 | 0.0009 | 10.3 ± 3.0 | 10.7 ± 3.9 | 0.4543 |
| Potential renal acid load score (mEq/day) | 3.1 ± 11.2 | 8.2 ± 11.9 | 0.0079 | 9.4 ± 8.8 | 2.0 ± 13.2 | 0.0001 |
| Net endogenous acid production score (mEq/day) | −8.7 ± 0.3 | −8.6 ± 0.3 | 0.0235 | −8.6 ± 0.3 | −8.7 ± 0.3 | 0.0049 |
Data are number of patients or mean ± standard deviation.
HbA1c, hemoglobin A1c
NEAP, net endogenous acid production
PRAL, potential renal acid load.
Odds ratios for prevalence of metabolic syndrome (logistic regression) according to the median of animal or vegetable protein energy/total energy or potential renal acid load or net endogenous acid production score
| OR (95% CI) |
| ||
|---|---|---|---|
| Animal protein energy/total energy | |||
| ≤7.7% ( | ≥7.8% ( | ||
| Unadjusted OR | 1 (Reference) | 0.92 (0.48–1.76) | 0.8113 |
| Adjusted OR | 1 (Reference) | 1.17 (0.52–2.60) | 0.6978 |
| Vegetable protein energy/total energy | |||
| ≤6.5% ( | ≥6.6% ( | ||
| Unadjusted OR | 1 (Reference) | 0.30 (0.15–0.59) | 0.0005 |
| Adjusted OR | 1 (Reference) | 0.28 (0.12–0.66) | 0.0038 |
| PRAL score | |||
| ≤6.9 mEq/day ( | ≥7.0 mEq/day ( | ||
| Unadjusted OR | 1 (Reference) | 2.49 (1.28–4.84) | 0.0083 |
| Adjusted OR | 1 (Reference) | 2.22 (1.04–4.83) | 0.0384 |
| NEAP score | |||
| ≤−8.7 mEq/day ( | ≥−8.6 mEq/day ( | ||
| Unadjusted OR | 1 (Reference) | 2.79 (1.43–5.46) | 0.0029 |
| Adjusted OR | 1 (Reference) | 2.61 (1.25–5.55) | 0.0098 |
Adjusted for age, sex, serum uric acid and creatinine, total energy intake, carbohydrate intake and sodium intake.
CI, confidence interval.
NEAP; net endogenous acid production
OR, odds ratio
PRAL, potential renal acid load.